Analysts have been eager to weigh in on the Technology sector with new ratings on BAE Systems (BAESF – Research Report), Marvell (MRVL – Research Report) and Health Catalyst (HCAT – Research Report).
BAE Systems (BAESF)
In a report released yesterday, David Perry from J.P. Morgan downgraded BAE Systems to Hold, with a price target of p965.00. The company’s shares closed last Friday at $9.61.
Perry has an average return of
According to TipRanks.com, Perry is ranked #7631 out of 8001 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for BAE Systems with a $11.54 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Marvell (MRVL)
In a report issued on August 26, Harlan Sur from J.P. Morgan maintained a Buy rating on Marvell, with a price target of $85.00. The company’s shares closed last Friday at $50.17.
According to TipRanks.com, Sur is a 5-star analyst with an average return of
Marvell has an analyst consensus of Strong Buy, with a price target consensus of $72.68, representing a 34.0% upside. In a report issued on August 26, KeyBanc also maintained a Buy rating on the stock with a $75.00 price target.
Health Catalyst (HCAT)
J.P. Morgan analyst Anne Samuel upgraded Health Catalyst to Buy yesterday and set a price target of $16.00. The company’s shares closed last Friday at $12.04, close to its 52-week low of $10.95.
According to TipRanks.com, Samuel is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Health Catalyst with a $18.86 average price target, implying a 54.3% upside from current levels. In a report issued on August 16, Berenberg Bank also maintained a Buy rating on the stock with a $17.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BAESF:
